As the pandemic continues to challenge the market, Argus will discuss their forecast for 2022 on Tuesday, December 14th at 2 pm Eastern Time.
Visiongain released a new report "Contract Manufacturing Outsourcing (CMO) for the Sterile Injection Drug Market Report 2021-2031: By molecular type
San Francisco, California, USA and Suzhou, China I December 6, 2021 I Innovent Biologics, Inc. ("Innovent") (Hong Kong Stock Exchange code: 01801), a world-class biopharmaceutical company for the treatment of tumors, metabolism, and autoimmunity And other major diseases, announced that IBI362 (LY
We use cookies to enhance your experience. By continuing to browse this website, you agree to our use of cookies. More information.
Note: This Consumer Medical Information (CMI) is for people living in Australia.
In this interview, we interviewed Dr. Georg Meisl and introduced his
The latest D-pyroglutamic acid market research report provides a 360-degree analysis of historical, current and future trends to help companies identify key factors affecting industry behavior from 2021 to 2027. In addition, it uses tested research methods to predict growth rates, scale, shares,
We use cookies to enhance your experience. By continuing to browse this website, you agree to our use of cookies. More information.
Since the start of the coronavirus disease (COVID-19) pandemic in 2019, many antibody therapies have been developed to treat severe acute respiratory syndrome
Reassessing fundamentals can lead to significant investment returns year after year.
Jim Schwartz, Head of Research, Agronomy, and Practical Farm Research (PFR) at Beck's Hybrids, said: "By doing the basic work better, you can add a lot of profitability to your bottom line."
More than 5000 solutions were found. Track your investment portfolio 24X7
MC30 is a select basket of 30 mutual fund (MF) programs worth investing in.
A new-age digital currency that diversifies investment portfolios.
Visit this section to access real-time prices and charts.
<© 2021 MJH Life Science and Pharmacy Times. all rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. all rights reserved.
Treatment Innovations for Relapsed/Refractory Borderline Zone Lymphoma-Episode 7
Beyond BTK inhibition in marginal zone lymphoma, the panelists
As the pandemic continues to challenge the market, Argus will discuss their forecast for 2022 on Tuesday, December 14th at 2 pm Eastern Time.
CD73 inhibition overcomes immunosuppression and shows activity in the detection of patients with relapsed or refractory multiple myeloma, providing p
As the pandemic continues to challenge the market, Argus will discuss their forecast for 2022 on Tuesday, December 14th at 2 pm Eastern Time.
– ASH supports the new discovery of the development strategy of KO-539 in KMT2A rearrangement and NPM1 mutant AML –
San Diego, December 13,